CN Patent

CN114585633A — 寡核苷酸缀合物组合物和使用方法

Assigned to Mina Therapeutics Ltd · Expires 2022-06-03 · 4y expired

What this patent protects

本公开涉及包含至少一个GalNAc单体的GalNAc部分。本公开还涉及包含GalNAc部分和寡核苷酸例如saRNA或siRNA的GalNAc‑寡核苷酸缀合物，用于调节靶基因的表达。还提供了使用GalNAc‑寡核苷酸缀合物的方法。

USPTO Abstract

本公开涉及包含至少一个GalNAc单体的GalNAc部分。本公开还涉及包含GalNAc部分和寡核苷酸例如saRNA或siRNA的GalNAc‑寡核苷酸缀合物，用于调节靶基因的表达。还提供了使用GalNAc‑寡核苷酸缀合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114585633A
Jurisdiction
CN
Classification
—
Expires
2022-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Mina Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.